CO NECTAR
Live / Allowed — Notice of allowance issued (as of 04 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Dec 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98911999
- Mark type
- Design + words
- Filed
- 19 Dec 2024
- Published for opposition
- 15 Jul 2025
- Attorney of record
- Simone Chen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; medicines for human purposes, namely, medicinal preparations for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; pharmaceutical preparations for prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; chemical preparations for medical purposes, namely, for disease prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; biological preparations for medical purposes for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; immunostimulants; radioactive substances for medical purposes; chemico-pharmaceutical preparations; vaccines; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes used by medical laboratories; chemical preparations for pharmaceutical purposes, namely, for disease prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease
- Class 042 — Scientific and technological services: Chemical research; chemical analysis; research and development services in the field of chemistry; biological research; bacteriological research; scientific research in the nature of conducting clinical trials for others; medical research; scientific research in the field of genetics; consulting services in the field of pharmaceutical research and development; research and development of new products for third parties in the scientific and medical field; research and development of new products for others; technological research in the field of pharmaceutical studies; conducting scientific study and research in the fields of medicine, prevention, treatment and management of illness, health care delivery, disease detection and treatment; technical writing; scientific laboratory services; scientific research; technological consultancy in the field of pharmaceuticals; culturing of cells for others for scientific research purposes; laboratory services for biomanufacturing.
Owner
- HoneyBear Biosciences, Inc., Taipei City, TW
- HoneyBear Biosciences, Inc., Taipei City, TW
Prosecution history
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Sept 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 14 Aug 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 15 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Jul 2025 — PUBLISHED FOR OPPOSITION
- 09 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jun 2025 — EXAMINER'S AMENDMENT ENTERED
- 11 Jun 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 Jun 2025 — EXAMINERS AMENDMENT E-MAILED
- 11 Jun 2025 — EXAMINERS AMENDMENT -WRITTEN
- 05 Jun 2025 — ASSIGNED TO EXAMINER
- 28 May 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 28 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Dec 2024 — NEW APPLICATION ENTERED